Newsletter January 2024 No.219
Top News
On October 17, 2023, a special session of the Pharmaceutical Manufacturers Association of Japan (PMAJ) was held at the 10th Nikkei-FT Conference on Infectious Diseases. The theme of the session was "Toward the Establishment of a Drug Discovery Ecosystem in the Field of Infectious Diseases: A Year in Review and Future Initiatives," and discussions were held from the perspectives of industry, academia and government on issues and strategies necessary to make the drug discovery ecosystem in the field of infectious diseases sustainable, based on the progress from 2022.
Topics
- The 22nd Pharmaceutical Association of Japan Forum
- Held the "5th Japan-Korea Symposium on Medical Product Regulations
- The 11th Japan-Taiwan Pharmaceutical Exchange Conference held
- ICH Prague Meeting" was held.
- Briefing session on the revision of the "Guidelines for the Preparation of Product Information Summaries for Ethical Drugs" was held
- The 40th Public Relations Seminar" was held - SNS and Web Literacy Seminar
- Holding of "FY2023 General Meeting of the Drug Evaluation Committee"
Breakthrough to Drug Loss -Aiming to realize safe, secure and wellbeing medical care and society - Report on "BioJapan 2023" Opening Ceremony, Keynote Speech, and Biopharmaceutical Committee Seminar
Explanation
Policy Research Institute page
From JPMA
At the Beginning of the Year 2024